Smoking and vaping patterns during pregnancy and the postpartum: A longitudinal UK cohort survey.


Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
12 2021
Historique:
received: 25 02 2021
revised: 09 06 2021
accepted: 12 07 2021
pubmed: 4 8 2021
medline: 21 9 2021
entrez: 3 8 2021
Statut: ppublish

Résumé

There is limited information about longitudinal patterns of vaping during pregnancy and the postpartum. We describe the prevalence, frequency, and reasons for vaping throughout pregnancy and postpartum. We also describe temporal patterns in pregnant women's vaping. A longitudinal cohort study across England and Scotland, with questionnaires in early pregnancy (8-24 weeks gestation), late pregnancy (34-38 weeks) and 3 months postpartum. A total of 750 women, aged 16 years or over, who were either current smokers, vapers or had smoked in the 3 months before pregnancy, were recruited between June and November 2017. Vaping prevalence was 15.9% (n = 119/750) in early pregnancy: 12.4% (n = 93/750) were dual users and 3.5% (n = 26/750) exclusive vapers. Late pregnancy vaping prevalence was 17.8% (n = 68/383): 12.5% (n = 48/383) were dual users and 5.2% (n = 20/383) exclusive vapers. Postpartum vaping prevalence was 23.1% (n = 95/411): 14.6% (n = 60/411) were dual users and 8.5% (n = 35/411) exclusive vapers. The most frequently reported reason to vape among all vapers was to quit smoking. A total of 316 women completed all three surveys: 2.6% (n = 8/316) were exclusive vapers in early pregnancy with most remaining exclusive vapers postpartum (n = 6/8, 75%). Of the 11.5% (n = 35/316) dual users in early pregnancy, 31.4% (n = 11/35) were exclusive smokers by the postpartum. Vaping prevalence was between 15.9% and 23.1% during pregnancy and the postpartum period, and the majority were dual users. Vaping habits of exclusive vapers remains stable throughout pregnancy and the postpartum. However, the vaping habits of dual users varies, with a third exclusively smoking in the postpartum.

Identifiants

pubmed: 34343923
pii: S0306-4603(21)00235-5
doi: 10.1016/j.addbeh.2021.107050
pmc: PMC8434421
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107050

Subventions

Organisme : Cancer Research UK
ID : C53479/A22733
Pays : United Kingdom

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

MMWR Morb Mortal Wkly Rep. 2019 Mar 01;68(8):189-194
pubmed: 30817748
BMC Pregnancy Childbirth. 2018 Jun 15;18(1):233
pubmed: 29902987
Obstet Gynecol. 2003 Jan;101(1):140-7
pubmed: 12517659
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Am J Prev Med. 2003 Jan;24(1):29-35
pubmed: 12554021
Ann Intern Med. 2017 Mar 21;166(6):390-400
pubmed: 28166548
Nicotine Tob Res. 2004 Apr;6 Suppl 2:S125-40
pubmed: 15203816
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
Paediatr Perinat Epidemiol. 2005 Sep;19(5):368-76
pubmed: 16115289
BMC Public Health. 2019 Jul 18;19(1):964
pubmed: 31319846
BJOG. 2020 May;127(6):750-756
pubmed: 32036628
Br J Addict. 1989 Jul;84(7):791-9
pubmed: 2758152
Tob Induc Dis. 2019 May 21;17:44
pubmed: 31516487
Neurotoxicol Teratol. 2012 Nov-Dec;34(6):560-70
pubmed: 23022448
Midwifery. 2019 Dec;79:102533
pubmed: 31499382
J Womens Health (Larchmt). 2020 Jun;29(6):780-788
pubmed: 32109175
JAMA Pediatr. 2019 Jun 1;173(6):600-602
pubmed: 31034001
JAMA Netw Open. 2018 Dec 7;1(8):e185937
pubmed: 30646298
Prev Med. 2017 Nov;104:50-56
pubmed: 28789981
Am J Prev Med. 2020 Aug;59(2):187-195
pubmed: 32362509
Int J Environ Res Public Health. 2014 Apr 22;11(4):4356-73
pubmed: 24758891
Public Health. 2007 Nov;121(11):861-8
pubmed: 17606278
BJOG. 2021 May;128(6):984-993
pubmed: 33012050
Public Health Res Pract. 2016 Apr 15;26(2):
pubmed: 27734060
Obstet Gynecol Surv. 2018 Sep;73(9):544-549
pubmed: 30265741
Matern Child Health J. 2017 Aug;21(8):1655-1661
pubmed: 28084577
N Engl J Med. 2008 Jul 3;359(1):61-73
pubmed: 18596274
Am J Public Health. 2004 Mar;94(3):361-6
pubmed: 14998794
Thorax. 2011 Oct;66(10):847-55
pubmed: 21325144
Addiction. 2016 Jun;111(6):981-90
pubmed: 26990248
BMJ Open. 2017 Nov 15;7(11):e018746
pubmed: 29146659
Cochrane Database Syst Rev. 2020 Oct 14;10:CD010216
pubmed: 33052602
Addiction. 2016 Sep;111(9):1656-65
pubmed: 26997495
Matern Child Health J. 2021 Apr;25(4):656-665
pubmed: 33211261
Nicotine Tob Res. 2009 Feb;11(2):111-21
pubmed: 19246425
BMJ. 2016 Apr 27;353:i1745
pubmed: 27122374
BMJ Open. 2014 May 14;4(5):e004915
pubmed: 24833689
J Obstet Gynecol Neonatal Nurs. 2016 May-Jun;45(3):320-5
pubmed: 27083420
Arch Dis Child. 2017 Feb;102(2):117-118
pubmed: 28100555
Respir Res. 2018 Aug 31;19(1):164
pubmed: 30170593
Addiction. 2017 Sep;112(9):1620-1628
pubmed: 28504457
J Addict Med. 2015 Jul-Aug;9(4):266-72
pubmed: 25974378
Acta Paediatr. 2020 Jun;109(6):1112-1124
pubmed: 31821600
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054

Auteurs

Katharine Bowker (K)

Division of Primary Care Research and UK Centre for Tobacco and Alcohol Studies, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK. Electronic address: Katharine.bowker@nottingham.ac.uk.

Sarah Lewis (S)

Division of Epidemiology and Public Health and UK Centre for Tobacco and Alcohol Studies, University of Nottingham, Clinical Sciences Building 2, Nottingham City Hospital Hucknall Road, Nottingham NG5 1PB, UK.

Michael Ussher (M)

Population Health Research Institute, St George's, University of London, London SW17 0RE, UK; Institute for Social Marketing and Health, University of Stirling, Stirling FK9 4LA, UK.

Felix Naughton (F)

University of East Anglia, Faculty of Medicine and Health Sciences, Edith Cavell Building, Norwich NR4 7TJ, UK.

Lucy Phillips (L)

Division of Primary Care Research and UK Centre for Tobacco and Alcohol Studies, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.

Tim Coleman (T)

Division of Primary Care Research and UK Centre for Tobacco and Alcohol Studies, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.

Sophie Orton (S)

Division of Primary Care Research and UK Centre for Tobacco and Alcohol Studies, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.

Hayden McRobbie (H)

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2031, Australia.

Linda Bauld (L)

Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, EH16 4UX, UK.

Sue Cooper (S)

Division of Primary Care Research and UK Centre for Tobacco and Alcohol Studies, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH